Vascular Perfusion Solutions Collaborates with Wyss

SAN ANTONIO, April 13, 2022 (GLOBE NEWSWIRE) — To improve its analysis on extending the viability of organs outdoors the physique for the aim of organ transplant, Vascular Perfusion Solutions (VPS) has entered right into a collaboration with the Wyss Institute for Biologically Inspired Engineering at Harvard University and the U.S. Air Force to check a compound found by the Institute to induce biostasis – a kind of metabolic hibernation that locations residing cells right into a state of suspended animation. VPS is the creator of the VP.S Encore™ machine, a novel, self-contained transport machine that makes use of oxygen to protect vascularized tissue for greater than eight hours, enabling hearts to stay viable past the present customary of care.

“We have been very excited when the invitation got here to companion with the Wyss Institute. We noticed the potential for synergy between the 2 applied sciences, and mentioned ‘sure’ straight away,” mentioned Mark Muller, J.D., the CEO of VPS.

For the previous 50 years, organs and different tissues have been preserved by cooling them all the way down to the purpose the place cells’ metabolism slows sufficient to increase their lifespan, permitting human organs akin to hearts to be saved viable for about 4 to 6 hours outdoors the physique. However, this time turns into a big impediment when organs should journey lengthy distances from their donors to their recipients. The Wyss Institute’s biostasis-inducing compound and the VP.S Encore™ machine each circumvent this drawback as a result of they will function at room temperature, and  confirmed promising ends in a 2020 massive animal pilot examine funded by the Defense Advanced Research Projects Agency (DARPA).

“Our hope is that this examine will additional validate applied sciences from each organizations, uncover their potential to assist lengthen the restricted window of alternative to deal with individuals affected by traumatic accidents, and enhance the standard and extent of their restoration,” mentioned Mike Super, Ph.D., a Lead Senior Staff Scientist on the Wyss Institute who manages the Institute’s Biostasis venture.

The Wyss Institute crew led by its Founding Director Donald Ingber, M.D., Ph.D. (who can be the principal investigator of the DARPA Biostasis grant), the U.S. Air Force 59^th Medical Wing collaborators, and VPS researchers offered the outcomes of their pilot examine to DARPA officers, who have been impressed and agreed to allocate a further $1.8 million to fund a bigger examine to validate the outcomes from the pilot examine. Beginning in 2022, the brand new funds from DARPA will probably be used to check extra Wyss-discovered compounds on totally different tissue sorts, together with muscle flaps and entire hearts, utilizing the VPS medical machine in collaboration with the 59^TH Medical Wing. This effort will probably be led by Col. Erik Weitzel, M.D., Chief of Operational Medicine within the US Air Force’s 59th Medical Wing, and Thomas Percival, M.D, Staff Cardiothoracic Surgeon working in collaboration with Ingber, Super and their Wyss crew.

About Vascular Perfusion Solutions (VPS)

Vascular Perfusion Solutions, Inc. is a improvement and early-stage firm, shaped for the aim of commercializing new, distinctive, and revolutionary oxygenated perfusion preservation and resuscitation options for the physique’s limbs, organs, and different vascularized tissue. Visit www.vascularperfusion.solutions to study extra.

The Wyss Institute for Biologically Inspired Engineering at Harvard University 

(www.wyss.harvard.edu) is a analysis and improvement engine for disruptive innovation powered by bioinspired applied sciences with visionary individuals at its coronary heart. Our mission is to rework healthcare and the atmosphere by creating ground-breaking applied sciences that emulate the way in which Nature builds and speed up their translation into business merchandise via the formation of startups and company partnerships to result in optimistic near-term impression on the earth. We accomplish this by breaking down the standard silos of academia and limitations with business, enabling our world-leading college to collaborate creatively throughout our focus areas of diagnostics, therapeutics, medtech, and sustainability. Our consortium companions embody the main educational establishments and hospitals within the Boston space and all through the world, together with Harvard’s Schools of Medicine, Engineering, Arts & Sciences, and Design, Beth Israel Deaconess Medical Center, Brigham and Women’s Hospital, Boston Children’s Hospital, Dana–Farber Cancer Institute, Massachusetts General Hospital, the University of Massachusetts Medical School, Spaulding Rehabilitation Hospital, Boston University, Tufts University, Charité – Universitätsmedizin Berlin, University of Zürich, and Massachusetts Institute of Technology. 

 

# # #